Market movers: Amazon, Freeport-McMoRan, SharpLink, HIVE, Medicus Pharma…

US President Donald Trump said Tuesday he plans to impose a 50% tariff on copper as part of a sweeping set of sector-specific trade measures targeting metals, semiconductors, and pharmaceuticals. Copper futures in New York surged as much as 17% following the remarks, marking the largest intraday gain since at least 1988. Sales during the first four hours of Amazon.com Inc (NASDAQ:AMZN)[1]'s annual Prime Day shopping event dropped nearly 14% from the same period last year, according to a report from retail data firm Momentum Commerce, weighing on the e-commerce giant's shares on Tuesday.

Amazon extended this year's event to four days from the usual two, a move that may be dispersing spending over a longer period. SharpLink Gaming Ltd shares jumped after the company said it has acquired 7,689 Ether (ETH) bringing its total ETH holdings to around 205,634. The Nasdaq-listed firm purchased the digital assets at an average price of £2,501 per ETH, underscoring a rapidly accelerating corporate strategy focused on Ethereum.

HIVE Digital Technologies (TSX-V:HIVE, NASDAQ:HIVE)[2] announced an 18% month-over-month increase in Bitcoin production in June, mining 164 Bitcoin compared to 139 in May. The increased output was driven by progress at HIVE's 100 megawatt (MW) Phase 1 facility in Paraguay, the company said on Tuesday. Medicus Pharma (NASDAQ:MDCX)[3] announced that it has submitted a formal request to the US Food and Drug Administration (FDA) for a Type C meeting to discuss the clinical development pathway for its dissolvable doxorubicin-containing microneedle array (D-MNA) product targeting basal cell carcinoma (BCC) of the skin.

The company is seeking a meeting during the week of October 6, aiming to gain the agency's approval to fast-track the program and seek feedback on future clinical plans. Nextech3D.ai (CSE:NTAR, OTCQX:NEXCF)[4] announced it has expanded its core team with a wave of strategic hires ahead of its upcoming fiscal 2024 audited financial results, set to be released on July 29.  The company, which specializes in AI-driven photorealistic 3D models and spatial experiences, said that the new additions reflect its commitment to operational transformation and long-term growth as part of an ongoing turnaround strategy.

Shares in Celebrus Technologies PLC (AIM:D4T4, OTC:DFORF)[5] rose 12% after the data software group announced two significant contract wins, adding £1.1 million to its annual recurring revenue and pushing total ARR close to £20 million.

The first contract, a three-year deal with a European bank undergoing a digital overhaul, will see the Celebrus Cloud platform used to power hyper-personalised customer experiences.

References

1. ^ Amazon.com Inc (NASDAQ:AMZN) (www.proactiveinvestors.co.uk)
2. ^ HIVE Digital Technologies (TSX-V:HIVE, NASDAQ:HIVE) (www.proactiveinvestors.co.uk)
3. ^ Medicus Pharma (NASDAQ:MDCX) (www.proactiveinvestors.co.uk)
4. ^ Nextech3D.ai (CSE:NTAR, OTCQX:NEXCF) (www.proactiveinvestors.co.uk)
5. ^ Celebrus Technologies PLC (AIM:D4T4, OTC:DFORF) (www.proactiveinvestors.co.uk)